Incyte Corporation has filed an 8-K report with the SEC, announcing the resignation of Susanne Schaffert from its Board of Directors, effective April 15, 2026. Dr. Schaffert has been a member of the Board since 2022. The company stated that her resignation was not due to any disagreement regarding the company's operations, policies, or practices. The Board expressed gratitude for her contributions during her tenure. This change in leadership is part of the company's ongoing governance and operational adjustments. The filing does not indicate any immediate impact on the company's strategic direction or financial performance, and thus is considered neutral in its effect on stock price.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.